Anti-PD-l1 antibody formulations

MYPI2025005130A0Undetermined Publication Date: 2021-06-09GENENTECH INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025005130
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-12-09
Filing Date
2020-12-07
Publication Date
2021-06-09
Patent Text Reader

Abstract

The invention provides liquid pharmaceutical formulations comprising an anti-PD-L1 antibody, such as liquid pharmaceutical formulations for subcutaneous administration. The invention also provides methods for making such formulations and methods of using such formulations. (FIG. 9B)
Need to check novelty before this filing date? Find Prior Art